Skip to main content

Advertisement

SpringerLink
Log in

Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

A retrospective study was made on 37 children with idiopathic nephrotic syndrome (INS). At the beginning, all patients were steroid sensitive but received more than one steroid course (median 4). Following several relapses, they became steroid dependent or steroid resistant. Group 1 consisted of 22 children [3 focal segmental glomerulosclerosis (FSGS), 19 minimal-change NS (MCNS)] who received cyclophosphamide (CP) orally for 2.5 ± 0.5 months. Group 2 consisted of 15 children (7 FSGS, 8 MCNS) who received cyclosporine-A (CSA) for 28 ± 15 months. The level of proteinuria decreased significantly and remained low during the follow-up. The relapse-free period was significantly longer in the CP group (CP 30 ± 21.5; CSA 26.2 ± 18 months, p < 0.001). The relapse rate decreased significantly in both groups and remained in this lower level during the follow-up (from 3.4 ± 2.8 to 0.1 ± 0.2/year in group 1, and from 3.7 ± 3.1 to 0.6 ±  0.8/year in group 2). At the end of the 5-year follow-up, 20/22 patients (90.9%) and 10/15 patients (66.6%) were in remission in groups 1 and 2 respectively, with or without treatment (p < 0.05). In the long term, both CP and CSA is effective second-line therapy following steroid monotherapy in INS patients, but the relapse rate was lower and the relapse free period was significantly longer in the CP-treated group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ehrich JH, Brodehl J (1991) Long versus standard prednisolone therapy for initial treatment of idiopathic nephrotic syndrome in children (Arbeitsgemeinschaft für Padiatrische Nephrologie). Eur J Pediatr 150:380–387

    Article  Google Scholar 

  2. Abeyagunawardena AS, Dillon MJ, Rees L, van’t Hoff W, Trompeter RS (2003) The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome. Pediatr Nephrol 18:919–924

    Article  PubMed  Google Scholar 

  3. Sümegi V, Haszon I, Ivanyi B, Bereczki Cs, Papp F, Turi S (2004) Long-term effects of levamisole treatment in childhood nephrotic syndrome. Pediatr Nephrol 19:1354–1360

    Article  PubMed  Google Scholar 

  4. Report of a workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians (1994) Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Arch Dis Child 71:151–157

    Article  Google Scholar 

  5. Bircan Z, Kara B (2003) Intravenous cyclophosphamide is the drug of choice for steroid dependent nephrotic syndrome. Pediatr Int 45:65–67

    Article  CAS  PubMed  Google Scholar 

  6. Chisthi AS, Solof JM, Brewer ED, Kale AS (2001) Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 38:754–760

    Article  Google Scholar 

  7. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639

    Article  PubMed  Google Scholar 

  8. Zietse R, Derkx FH, Schalekamp MA, Weimar W (1995) Cyclosporine and the glomerular filtration barrier in minimal change disease and membranous nephropathy. Contrib Nephrol 114:6–18

    Article  CAS  PubMed  Google Scholar 

  9. Borel JF, Feurer C, Gubler HU, Stahelin H (1994) Biological effects of cyclosporine A: A new antilymphocytic agent. 1976. Agents Actions 43:179–186

    Article  CAS  PubMed  Google Scholar 

  10. Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo-P G, Hallman N, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet 1:959–961

    Article  CAS  PubMed  Google Scholar 

  11. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS; National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416–1421

    PubMed  Google Scholar 

  12. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N (2001) Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 16:723–727

    Article  CAS  PubMed  Google Scholar 

  13. Lijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa H (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801–1805

    Article  Google Scholar 

  14. McCrory WW, Shibuya M, Lu WH, Lewy JE (1973) Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome. J Pediatr 82:614–618

    Article  CAS  PubMed  Google Scholar 

  15. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Della Casa-Alberighi O (1993) Cyclosporine versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326–1332

    CAS  PubMed  Google Scholar 

  16. Niaudet P (1992) Comparison of cyclosporine and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 6:1–3

    Article  CAS  PubMed  Google Scholar 

  17. Pena A, Bravo J, Melgosa M, Fernandez C, Meseguer C, Espinosa L, Alonso A, Navarro M (2007) Steroid-resistant nephritic syndrome: long-term evolution after sequential therapy. Pediatr Nephrol 22:1875–1880

    Article  PubMed  Google Scholar 

  18. Grupe WE, Heymann W (1966) Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. Am J Dis Child 112:448–458

    Article  CAS  PubMed  Google Scholar 

  19. Querfeld U, Waldherr R, Scharer K (1985) The significance of focal global sclerosis in idiopathic nephratic nephrotic syndrome. Long-term clinical observations. Acta Paediatr Scand 74:913–919

    Article  CAS  PubMed  Google Scholar 

  20. Report of the International Study Group of Kidney Disease in Children (1974) Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2:423–427

    Google Scholar 

  21. Geary DF, Farine M, Thorner P, Baumal R (1984) Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 22:109–113

    CAS  PubMed  Google Scholar 

  22. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451–454

    Article  Google Scholar 

  23. Williams SA, Makker SP, Ingelfinger JR, Grupe WE (1980) Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med 302:929–933

    Article  CAS  PubMed  Google Scholar 

  24. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1987) Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. Arch Dis Child 62:1102–1106

    Article  Google Scholar 

  25. Drummond KN, Hillman DA, Marchessault JH, Feldman W (1968) Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings. Can Med Assoc J 98:524–531

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Moncrieff MW, White RH, Oggs CS, Cameron JS (1969) Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J 1:666–671

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Rance CP, Arbus GS, Balfe JW (1976) Management of the nephrotic syndrome in children. Pediatr Clin North Am 23:735–750

    Article  CAS  PubMed  Google Scholar 

  28. Dundon S, O’Callaghan U, Raftery J (1980) Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide. Int J Pediatr Nephrol 1:22–25

    CAS  PubMed  Google Scholar 

  29. Griswold WR, Kaufman DB, Smith FG, McIntosh RM (1971) Cyclophosphamide in nephrotic syndrome. Clin Res 19:233

    Google Scholar 

  30. Latta K, von Schnakenburg C, Ehrich JH (2001) A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16:271–282

    Article  CAS  PubMed  Google Scholar 

  31. Barratt TM, Soothill JF (1970) Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 2:479–482

    Article  CAS  PubMed  Google Scholar 

  32. Ghose S, Kumar M, Kundu B, Bindal S (1977) Long-term follow up of steroid and cyclophosphamide therapy in nephrosis. Indian Pediatr 14:885–889

    CAS  PubMed  Google Scholar 

  33. Grushkin CM, Fine RN, Heuser E, Lieberman E (1970) Cyclophosphamide therapy of idiopathic nephrosis. Calif Med 13:1–5

    Google Scholar 

  34. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56:2220–2226

    Article  CAS  PubMed  Google Scholar 

  35. Durkan A, Hodson E, Willis N, Craig J (2003) Non-corticosteroid treatment for nephrotic syndrome in children (Cochrane Review) The Cochrane Library. 1. Oxford, Update Software Ltd

  36. Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ (2004) Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome. Nephrol Dial Transplant 19:1136–1141

    Article  CAS  PubMed  Google Scholar 

  37. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820–1825

    CAS  PubMed  Google Scholar 

  38. Sairam VK, Kaila A, Rajaraman S, Travis LB (2002) Secondary resistance to cyclosporin A in children with nephrotic syndrome. Pediatr Nephrol 17:842–846

    Article  PubMed  Google Scholar 

  39. Waldo FB, Benfield MR, Kohaut EC (1998) Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr Nephrol 12:397–400

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, University of Szeged, Faculty of Medicine, Korányi fasor 14-15, 6720, Szeged, Hungary

    Viktória Sümegi, Ibolya Haszon, Csaba Bereczki, Ferenc Papp & Sándor Túri

Authors
  1. Viktória Sümegi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ibolya Haszon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Csaba Bereczki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferenc Papp
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sándor Túri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Viktória Sümegi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sümegi, V., Haszon, I., Bereczki, C. et al. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 23, 1085–1092 (2008). https://doi.org/10.1007/s00467-008-0771-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-008-0771-8

Keywords

Search

Navigation